These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3683923)

  • 1. [Biomarkers in the control of the treatment of gastrointestinal carcinomas].
    Lorenzi M; Inaudi P; Caldarone R; Garzi A; Lorenzini L
    Minerva Chir; 1987 Oct; 42(20):1621-4. PubMed ID: 3683923
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor markers in the diagnosis of solid tumors].
    Koch OM
    Internist (Berl); 1992 Aug; 33(8):W79-86. PubMed ID: 1526714
    [No Abstract]   [Full Text] [Related]  

  • 3. [Curative interventions for recurrence of gastrointestinal carcinomas--incidence and prognosis].
    Hohenberger W; Altendorf-Hofmann A; Haas C
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():218-21. PubMed ID: 9101836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The "false positive" tumor marker in malignant testicular tumor].
    Bussar-Maatz R; Weissbach L; Dahlmann N; Mann K
    Urologe A; 1993 May; 32(3):177-82. PubMed ID: 8511831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dukes C2 colon cancer: what is appropriate follow-up?
    Semin Oncol; 1995 Jun; 22(3):xix; discussion xix-xx passim. PubMed ID: 7777864
    [No Abstract]   [Full Text] [Related]  

  • 6. False elevation of serum CA 15-3 levels in patients under follow-up for breast cancer.
    Aguiar-Bujanda D; Bohn-Sarmiento U; Aguiar-Morales J
    Breast J; 2004; 10(4):375-6. PubMed ID: 15239804
    [No Abstract]   [Full Text] [Related]  

  • 7. Follow-up of patients with gastrointestinal cancer by tumor marker determination.
    Lukinac L; Bolanca A; Nöthig-Hus D; Kusić Z
    Acta Med Croatica; 1997; 51(2):73-7. PubMed ID: 9204590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reresection for gastric carcinoma.
    Scheinin TM; Inberg MV; Linna MI
    Acta Chir Scand; 1968; 134(8):660-6. PubMed ID: 5713449
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results.
    Zervoudis S; Peitsidis P; Iatrakis G; Panourgias E; Koureas A; Navrozoglou I; Dubois JB
    J BUON; 2007; 12(4):487-92. PubMed ID: 18067207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The surveillance of gastrointestinal neoplasms after curative surgery].
    Mansikka A; Alhava E
    Duodecim; 2002; 118(8):789-95. PubMed ID: 12238193
    [No Abstract]   [Full Text] [Related]  

  • 13. [Follow-up of the CEA in gastrointestinal neoplasms after surgical intervention].
    Piantino P; Garrone C; Cattaneo U; Bonardi O; Toppino M; Pecchio F
    Minerva Dietol Gastroenterol; 1981; 27(4):541-5. PubMed ID: 7335225
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of serum zinc, copper, ceruloplasmin levels in patients with gastrointestinal tract cancers.
    Boz A; Evliyaoğlu O; Yildirim M; Erkan N; Karaca B
    Turk J Gastroenterol; 2005 Jun; 16(2):81-4. PubMed ID: 16252197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of blood assay of tumor markers for detecting recurrence of colorectal cancer].
    Pélissier E; Bosset JF; Meneveau N
    Bull Cancer; 1994 Dec; 81(12):1050-6. PubMed ID: 7742592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor markers--how they should be applied].
    Stieber P; Heinemann V; Schalhorn A
    MMW Fortschr Med; 2005 May; 147(20):35, 37-9. PubMed ID: 15957858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Search for tumor cells in the venous blood in relation to postoperative care of cancer patients].
    Peckholz I; Melchert R
    Zentralbl Chir; 1966 Sep; 91(36):1313-7. PubMed ID: 5995396
    [No Abstract]   [Full Text] [Related]  

  • 19. [After-care of gastrointestinal malignancies--an evaluation of costs and benefits].
    Zieren HU; Müller JM
    Zentralbl Chir; 1996; 121(3):167-76. PubMed ID: 8867342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important matters to identify robust markers for metastasis and recurrence in solid cancer.
    Mimori K; Iwatsuki M; Yokobori T; Mori M
    Ann Surg Oncol; 2009 Apr; 16(4):1070-1. PubMed ID: 19169757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.